Status:
ACTIVE_NOT_RECRUITING
The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Genetic Disease
Eligibility:
All Genders
3-75 years
Phase:
NA
Brief Summary
The eMERGE Network embraces the opportunity to use new methods in genomic medicine, information science, and research participant engagement to identify people at very high risk for specific diseases ...
Detailed Description
The purpose of the study is to determine if providing a Genome Informed Risk Assessment (GIRA) will impact clinical actions taken by providers and patients to manage disease risk and the propensity of...
Eligibility Criteria
Inclusion
- Adults 18-75
- Children 3 to \< 18
- Able to read or understand English or Spanish
- Able to provide a healthcare provider or clinician to receive results
- Willing to accept GIRA report
Exclusion
- Inability to provide consent
- Transplant (solid organ or bone marrow) or transfusion within 8 weeks
- Research staff and investigators in eMERGE
- Not a patient at parent institution
Key Trial Info
Start Date :
February 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
26877 Patients enrolled
Trial Details
Trial ID
NCT05277116
Start Date
February 16 2022
End Date
December 31 2026
Last Update
August 29 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama Birmingham
Birmingham, Alabama, United States, 35233
2
Mountain Park Health Center
Tempe, Arizona, United States, 85012
3
Northwestern
Chicago, Illinois, United States, 60611
4
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114